... 1,795 (22 %) 110 (18%) 38 (18%) 1,685 (23 %) 60-65 1,446 (18%) 122 (20 %) 45 (21 %) 1, 324 (18%) ≥ 65 2, 024 (25 %) 29 1 (47%) 1 02 (48%) 1,733 (24 %) BMI (kg·m -2) < 18.5 51 (1%) (1%) (1%) 48 (1%) 18.5 -25 .0 ... or 25 0 m Table Characteristics of the total population and of participants with and without typediabetes Characteristic Total population TypeDiabetes Screening diagnosed TypeDiabetes No Type ... region of the Netherlands Methods Study area and study population The study was performed among residents of the semirural area of Westfriesland in the North-West of the Page of Netherlands (Figure...
... Urso B & James DE (20 00) Signalling through theinsulin receptor Curr Opin Cell Biol 12, 22 2 22 8 Saltiel AR & Kahn CR (20 01) Insulin signalling andthe regulation of glucose and lipid metabolism ... 0.1–0 .2 1.1–1.8 0.6–0.7 0.3–0.4 0. 02 0.03 1.1–1.8 1.8 2. 0 0.6–0.7 0.1–0 .2 1.1–1.8 1.8 2. 0 0.6–0.7 0.1–0 .2 1.1–1.8 1.8 2. 0 0.6–0.7 0.1–0 .2 1.1–1.8 1.8 2. 0 0.6–0.7 0.1–0 .2 FEBS Journal 27 2 (20 05) ... normal subjects, but that this insulinresistance could 1 42 A Danielsson et al be reversed Theinsulinresistance in cells from patients with type diabetes, on the other hand, was not reversible Results...
... has been published diabetes is recognised as one of the more common risk factor for atherothrombosis [2] Both typediabetes (i.e insulin dependent) andtypediabetes (i.e not -insulin dependent) ... (table 2) Discussion The association between FVL and VTE is well known [11], while the association between FVL and atherothrombosis is still matter of discussion [ 12] On the other hand, the association ... Lipinska I, D'Agostino RB, Wilson PW: Hyperinsulinemia, hyperglycemia, and impaired hemostasis: the Framingham Offspring Study JAMA 20 00, 28 3 (2) :22 1 -22 8 Ceriello A, Giugliano D, Dello Russo P,...
... SYNDROME ANDTYPEDIABETES MELLITUS Recent advancements in the management of systemic glucose regulation in obesity/ T2DM include drug therapies designed to utilize components of the incretin system ... to determine the safety and efficacy in the MetS/T2DM population Glucagon-like Peptide and Systemic Glucose Regulation Recent advancements in the treatment of T2DM include drug therapies designed ... administration and/ or species differences Furthermore, the effects of GLP-1 on coronary blood flow and vascular tone are unknown in humans and in the settings of MetS/T2DM Further studies to determine the...
... D., Mandelbaum, A., Etinger, A & Mechoulam, R (19 92) Isolation and structure of a brain con- 20 21 22 23 24 25 26 27 28 29 30 31 32 stituent that bind to the cannabinoid receptor Science 25 8, ... N-terminal andthe first transmembrane domain of the protein of the human and rat CB2 receptor The specificity of theCB1and CB2 antibodies was described in McIntosh et al [41] and in Shire et al [ 42] , ... amount of anandamide and/ or 2- AG [21 ,23 26 ] IgE-dependent stimulation of RBL-2H3 cells also leads to the formation of anandamide and of its congener N-palmitoylethanolamine (PalEtn) [22 ], which...
... Ca (2+ ) influx by cannabinoid and metabotropic glutamate receptors Theendocannabinoidsystem in cerebral ischemia 22 23 24 25 26 27 28 29 30 31 32 33 34 35 FEBS Journal 27 6 (20 09) 2 12 ª 20 08 The ... cannabinoid CB1 receptors Eur J Pharmacol 423 , 20 3 21 0 81 Hillard CJ (20 00) Endocannabinoids and vascular function J Pharmacol Exp Ther 29 4, 27 – 32 82 Mathew RJ, Wilson WH & Davis R (20 03) Postural ... dissecting the role of theendocannabinoidsystem in physiology as well as in pathological processes Thesystem incorporates the endocannabinoids, their synthetic and degradative enzymes, the endocannabinoid...
... Uchimura H, Fujishima M & Hall ED (20 00) Ovariectomy exacerbates Endocannabinoidsystem modulation by E2 after MCAo 22 23 24 25 26 27 28 29 30 31 32 33 34 and estrogen replacement attenuates ... released into the extracellular space and interact with typeandtype cannabinoid (CB1 and CB2) receptors, non -CB1 ⁄ non-CB2 receptors, and noncannabinoid receptors, including thetype vanilloid ... supply may further FEBS Journal 27 4 (20 07) 4464–4475 ª 20 07 The Authors Journal compilation ª 20 07 FEBS Endocannabinoidsystem modulation by E2 after MCAo D Amantea et al Vehicle E2 ICI + E2 Infarct...
... (43.6%) 20 2 (56.4%) P < 0.001 ACSb Diagnoses (N, %) 322 97 (30.1%) 22 5 (69.9%) - other diagnoses 331 99 (29 .9%) 23 2 (70.1%) Age (years) 58 (19 to 87) 59 (22 to 87) 58 (19 to 86) P = 0 .21 4 Male ... the incidence of type diabetes: a systematic review Diabetes Care 20 02, 25 :18 62- 1868 50 Ben-Haroush A, Yogev Y, Hod M: Epidemiology of gestational diabetes mellitus and its association with Type ... KE, Saydah SH, Geiss LS: Full accounting of diabetesand pre -diabetes in the U.S population in 1988-1994 and 20 05 -20 06 Diabetes Care 20 09, 32: 287 -29 4 doi: 10.1186/cc9101 Cite this article as:...
... Bellazzi R., Nucci G & Cobelli C (20 01) The Subcutaneous Route to Insulin Dependent Diabetes Therapy: ... Slovenia from 20 03 to 20 52 6000 5000 20 52 number 4000 20 03 3000 20 00 1000 0 10 20 30 40 50 age [yeas] Fig 16 Number of D2 patients from 20 03 to 20 52 60 70 80 90 100 Burden of DiabetesType Through ... structure The results have showed that the residues at positions 15 21 and 24 – 32 are involved in the beta-sheet formation and that the turn at positions 22 and 23 plays a crucial role in the aggregation...